SCHEMBL20122516

SCHEMBL20122516

CC(C)(SC(=O)OCOC(=O)c1ccccc1)C(=O)N[C@@H](CSC(=O)OCOC(=O)c1ccccc1)C(=O)OCOC(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 6/20 0.41
▸ ADRB1 P08588 6/20 0.41
▸ ADRB3 P13945 6/20 0.41
▸ ALDH1A1 P00352 1/20 0.37
▸ TDP1 Q9NUW8 3/20 0.36
▸ SLC6A3 Q01959 2/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ SCN1A P35498 1/20 0.36
▸ SCN5A Q14524 1/20 0.36
▸ SCN2A Q99250 1/20 0.36
▸ SCN3A Q9NY46 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TSHR P16473 1/20 0.33
▸ PPARG P37231 2/20 0.33
▸ PPARD Q03181 2/20 0.33
▸ PPARA Q07869 2/20 0.33
▸ IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122556 0.95 ADRB2 (0.39) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122555 0.95 ADRB2 (0.40) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122445 0.94 ADRB2 (0.41) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122394 0.93 KMT2A (0.42) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122388 0.93 ADRB2 (0.39) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122393 0.92 ADRB2 (0.38) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122558 0.92 ADRB2 (0.38) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122500 0.87 ADRB2 (0.40) ADRB2ADRB1ADRB3ALDH1A1TDP1
SCHEMBL20122395 0.87 LMNA (0.37) ADRB2ADRB1ADRB3ALDH1A1CYP2D6
SCHEMBL20122515 0.86 ADRB2 (0.33) ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback